Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity,Immunity, Inflammation and Disease

当前位置： X-MOL 学术 › Immun. Inflamm. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity
Immunity, Inflammation and Disease ( IF 3.1 ) Pub Date : 2021-01-16 , DOI: 10.1002/iid3.402
Archana Kulkarni-Munje ₁ , Sonali Palkar ₂ , Shubham Shrivastava ₁ , Sanjay Lalwani ₂ , Akhilesh C Mishra ₁ , Vidya A Arankalle ₁

Affiliation

Infection with SARS‐CoV‐2 leads to a spectrum of symptoms. Understanding the basis for severity remains crucial for better management and therapy development. So far, older age, associated‐comorbidities, and IL‐6 have been associated with severity/mortality.

中文翻译：

对出现轻度或重度症状的 SARS CoV-2 感染患者的免疫细胞亚群进行基于疾病持续时间的比较，以确定严重程度的预后标志物

感染 SARS-CoV-2 会导致一系列症状。了解严重程度的基础对于更好的管理和治疗开发仍然至关重要。到目前为止，年龄较大、相关合并症和 IL-6 与严重程度/死亡率相关。

更新日期：2021-01-16

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文